
Jenny Elsa Blau MD
Diabetes, Lipid Metabolism
Senior Medical Director Early Clinical Development, CVRM Astra Zeneca Adjunct Associate Research Clinician Metabolic Disease Branch NIDDK
Join to View Full Profile
1 Medimmune WayGaithersburg, MD 20878
Dr. Blau is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2012 - 2015
- MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 2009 - 2012
- Georgetown University School of MedicineClass of 2009
Certifications & Licensure
- DC State Medical License 2011 - 2022
- VA State Medical License 2012 - 2014
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- Elevated levels of circulating microbial-associated uremic toxins are associated with metastatic duodenopancreatic neuroendocrine tumors in patients with Multiple Endo...Riccardo Ballarò, Amanda R Wasylishen, Carolina R C Pieterman, Courtney Olsen, Ehsan Irajizad
Cancer Letters. 2025-04-01 - Genotype-phenotype correlation in multiple endocrine neoplasia type 1.Charlita C Worthy, Rana Tora, Chandra N Uttarkar, James M Welch, Lynn Bliss
JCI Insight. 2025-02-13 - 1 citationsAZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trials.Javier Armisen, Mitra Rauschecker, Janeli Sarv, Mathias Liljeblad, Linda Wernevik
Journal of Hepatology. 2025-01-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: